STOCK TITAN

Saba Capital discloses 5.93% stake in Sharps Technology (STSS) shares

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Saba Capital Management and affiliates have reported a significant stake in Sharps Technology, Inc. In this amended Schedule 13G, Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein disclose beneficial ownership of 1,741,214 shares and warrants of Sharps Technology common stock, representing 5.93% of the class as of the event date of 12/31/2025.

The ownership percentage is based on 28,995,402 shares outstanding as of December 15, 2025, plus 388,462 shares issuable upon exercise of certain warrants held by the reporting persons. All voting and dispositive power over these securities is reported as shared, with no sole voting or dispositive power. The filing states that the securities were not acquired and are not held for the purpose of changing or influencing control of Sharps Technology, characterizing this as a passive investment position held on behalf of funds and accounts advised by Saba Capital.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The denominator of the fraction upon which the percentages are calculated is based on (i) 28,995,402 Shares outstanding as of December 15, 2025 as reported on the Issuer's 424B3 filed with the Securities and Exchange Commission on January 13, 2026 plus (ii) 388,462 Shares issuable upon the exercise of certain warrants held by the Reporting Persons.


SCHEDULE 13G




Comment for Type of Reporting Person: The denominator of the fraction upon which the percentages are calculated is based on (i) 28,995,402 Shares outstanding as of December 15, 2025 as reported on the Issuer's 424B3 filed with the Securities and Exchange Commission on January 13, 2026 plus (ii) 388,462 Shares issuable upon the exercise of certain warrants held by the Reporting Persons.


SCHEDULE 13G




Comment for Type of Reporting Person: The denominator of the fraction upon which the percentages are calculated is based on (i) 28,995,402 Shares outstanding as of December 15, 2025 as reported on the Issuer's 424B3 filed with the Securities and Exchange Commission on January 13, 2026 plus (ii) 388,462 Shares issuable upon the exercise of certain warrants held by the Reporting Persons.


SCHEDULE 13G



Saba Capital Management, L.P.
Signature:/s/ Michael D'Angelo
Name/Title:General Counsel
Date:01/15/2026
Boaz R. Weinstein
Signature:/s/ Michael D'Angelo
Name/Title:Authorized Signatory
Date:01/15/2026
Saba Capital Management GP, LLC
Signature:/s/ Michael D'Angelo
Name/Title:Attorney-in-fact*
Date:01/15/2026

Comments accompanying signature: * Pursuant to a Power of Attorney dated as of November 16, 2015

FAQ

What ownership stake in Sharps Technology (STSS) does Saba Capital report?

The reporting persons disclose beneficial ownership of 1,741,214 Sharps Technology common shares and warrants, representing 5.93% of the outstanding class.

Who are the reporting persons in this Sharps Technology (STSS) Schedule 13G/A?

The filing is made jointly by Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein, pursuant to a Joint Filing Agreement dated January 15, 2026.

How is the 5.93% ownership in Sharps Technology (STSS) calculated?

The 5.93% is based on 28,995,402 Sharps Technology shares outstanding as of December 15, 2025, plus 388,462 shares issuable upon exercise of certain warrants held by the reporting persons.

Does Saba Capital have sole or shared voting power over its Sharps Technology (STSS) position?

Each reporting person reports 0 shares with sole voting or dispositive power and 1,741,214 shares with shared voting and shared dispositive power.

Is Saba Capital seeking to influence control of Sharps Technology (STSS)?

The certification states that the securities were not acquired and are not held for the purpose of changing or influencing control of Sharps Technology and are not held in connection with any such transaction.

Who benefits economically from Saba Capital’s Sharps Technology (STSS) holdings?

The filing notes that the funds and accounts advised by Saba Capital have the right to receive dividends and proceeds from sales of the Sharps Technology common stock.
Sharps Tech

NASDAQ:STSS

STSS Rankings

STSS Latest News

STSS Latest SEC Filings

STSS Stock Data

66.69M
28.19M
0.08%
0.07%
2.79%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MELVILLE